The impact of angiotensin-converting enzyme inhibitors on managed care: economic, clinical, and humanistic outcomes.
Am J Manag Care
; 6(3 Suppl): S112-28, quiz S129-31, 2000 Feb.
Article
en En
| MEDLINE
| ID: mdl-10977441
ABSTRACT
This article examines evidence of the improved clinical, economic, and humanistic outcomes associated with the use of angiotensin-converting enzyme inhibitors (ACEIs) in clinical practice, in particular in the areas of hypertension, diabetic nephropathies, post-myocardial infarction, and congestive heart failure. Pharmacodynamic and pharmacokinetic differences may exist among this class, however, these may not be clinically relevant when the drugs are given in equivalent doses. Although additional studies are necessary before a class effect can be assumed for each of these outcomes, it is important for clinicians to consider all of these outcomes when using ACEIs.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Inhibidores de la Enzima Convertidora de Angiotensina
/
Programas Controlados de Atención en Salud
Tipo de estudio:
Health_economic_evaluation
Límite:
Humans
Idioma:
En
Revista:
Am J Manag Care
Asunto de la revista:
SERVICOS DE SAUDE
Año:
2000
Tipo del documento:
Article
País de afiliación:
Estados Unidos